Historical Valuation
Nephros Inc (NEPH) is now in the Fair zone, suggesting that its current forward PS ratio of 2.53 is considered Fairly compared with the five-year average of -24.00. The fair price of Nephros Inc (NEPH) is between 2.04 to 8.69 according to relative valuation methord.
Relative Value
Fair Zone
2.04-8.69
Current Price：4.81
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Nephros Inc (NEPH) has a current Price-to-Book (P/B) ratio of 5.04. Compared to its 3-year average P/B ratio of 2.89 , the current P/B ratio is approximately 74.55% higher. Relative to its 5-year average P/B ratio of 3.55, the current P/B ratio is about 42.09% higher. Nephros Inc (NEPH) has a Forward Free Cash Flow (FCF) yield of approximately 5.39%. Compared to its 3-year average FCF yield of -3.20%, the current FCF yield is approximately -268.07% lower. Relative to its 5-year average FCF yield of -7.23% , the current FCF yield is about -174.47% lower.
P/B
Median3y
2.89
Median5y
3.55
FCF Yield
Median3y
-3.20
Median5y
-7.23
Competitors Valuation Multiple
AI Analysis for NEPH
The average P/S ratio for NEPH competitors is 2.84, providing a benchmark for relative valuation. Nephros Inc Corp (NEPH.O) exhibits a P/S ratio of 2.53, which is -10.83% above the industry average. Given its robust revenue growth of 35.42%, this premium appears sustainable.
Performance Decomposition
AI Analysis for NEPH
1Y
3Y
5Y
Market capitalization of NEPH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of NEPH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is NEPH currently overvalued or undervalued?
Nephros Inc (NEPH) is now in the Fair zone, suggesting that its current forward PS ratio of 2.53 is considered Fairly compared with the five-year average of -24.00. The fair price of Nephros Inc (NEPH) is between 2.04 to 8.69 according to relative valuation methord.
What is Nephros Inc (NEPH) fair value?
NEPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Nephros Inc (NEPH) is between 2.04 to 8.69 according to relative valuation methord.
How does NEPH's valuation metrics compare to the industry average?
The average P/S ratio for NEPH's competitors is 2.84, providing a benchmark for relative valuation. Nephros Inc Corp (NEPH) exhibits a P/S ratio of 2.53, which is -10.83% above the industry average. Given its robust revenue growth of 35.42%, this premium appears sustainable.
What is the current P/B ratio for Nephros Inc (NEPH) as of Jan 10 2026?
As of Jan 10 2026, Nephros Inc (NEPH) has a P/B ratio of 5.04. This indicates that the market values NEPH at 5.04 times its book value.
What is the current FCF Yield for Nephros Inc (NEPH) as of Jan 10 2026?
As of Jan 10 2026, Nephros Inc (NEPH) has a FCF Yield of 5.39%. This means that for every dollar of Nephros Inc’s market capitalization, the company generates 5.39 cents in free cash flow.
What is the current Forward P/E ratio for Nephros Inc (NEPH) as of Jan 10 2026?
As of Jan 10 2026, Nephros Inc (NEPH) has a Forward P/E ratio of 39.58. This means the market is willing to pay $39.58 for every dollar of Nephros Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Nephros Inc (NEPH) as of Jan 10 2026?
As of Jan 10 2026, Nephros Inc (NEPH) has a Forward P/S ratio of 2.53. This means the market is valuing NEPH at $2.53 for every dollar of expected revenue over the next 12 months.